Merck’s HIV patent agreement ignites monopoly criticism
Monday, March 16, 2015 - 01:30
in Mathematics & Economics
The plan seems designed to avoid healthy competition that could drive down drug prices, one patent expert says.
Updated by artificial intelligence Tue, 13 Jun 2023, 2:53:47 UTC Learn more
- Tell your friends
- Get science news via